https://ir.markertherapeutics.com/ 2021-02-03T17:15:53-05:00 daily 1.0 https://ir.markertherapeutics.com/committee-details/audit-committee 2025-11-19T16:31:58-05:00 0.5 https://ir.markertherapeutics.com/committee-details/compensation-committee 2023-10-31T12:25:58-04:00 0.5 https://ir.markertherapeutics.com/committee-details/nominating-and-corporate-governance-committee 2025-11-19T16:33:04-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/virtual-oppenheimer-fall-healthcare-life-sciences-medtech-summit 2020-11-30T15:02:35-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/marker-therapeutics-third-quarter-2020-financial-and-operating-results 2020-11-30T15:05:21-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/update-phase-1-trial-pancreatic-adenocarcinoma-tactops 2021-01-22T17:48:59-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/virtual-oppenheimer-31st-annual-healthcare-conference 2021-03-15T11:57:03-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/marker-therapeutics-first-quarter-2021-financial-and-operating-results 2021-05-12T16:23:08-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/2021-american-society-gene-cell-therapy-asgct-annual-meeting 2021-06-02T16:33:53-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/raymond-james-human-health-innovation-conference 2021-06-17T12:33:46-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/hc-wainwright-annual-global-investment-conference 2021-09-23T13:37:09-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/oppenheimer-fall-healthcare-life-sciences-medtech-summit 2021-09-07T16:09:43-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/cantor-fitzgerald-global-healthcare-conference 2021-09-07T16:09:35-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/marker-therapeutics-clinical-program-update 2022-02-16T14:30:47-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/roth-annual-conference 2022-03-14T16:05:25-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/oppenheimer-virtual-annual-healthcare-conference 2022-09-08T10:25:05-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/33rd-annual-cancer-progress-conference 2022-04-26T14:13:09-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/cantor-fitzgerald-cell-and-genetic-medicines-conference 2022-09-08T10:21:02-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/kol-expert-webinar-beyond-car-t-whats-next-cell-therapy 2023-07-26T07:01:20-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/hc-wainwright-25th-annual-global-investment-conference 2023-08-30T07:45:00-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/hc-wainwright-2nd-annual-cell-therapy-virtual-conference 2024-03-22T13:00:57-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/2024-ladenburg-thalmann-co-virtual-oncology-innovators-investors-symposium 2024-12-18T13:44:29-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/citizens-jmp-hematology-and-oncology-summit 2024-12-10T10:38:15-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/hc-wainwright-3rd-annual-cell-therapy-virtual-conference 2025-02-25T07:43:29-05:00 0.5 https://ir.markertherapeutics.com/events/event-details/kol-webinar-seven-years-after-fda-approval-have-cd19-car-t-cells-met 2025-05-28T15:32:51-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/canaccord-genuity-45th-annual-growth-conference-marker-tx-fireside-chat 2025-07-30T08:02:52-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/marker-therapeutics-webcast-apollo-data 2025-08-26T07:32:20-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/marker-therapeutics-fireside-chat-hc-wainwright-conference 2025-08-28T08:02:12-04:00 0.5 https://ir.markertherapeutics.com/events/event-details/oppenheimer-36th-annual-healthcare-life-sciences-conference 2026-02-18T08:06:16-05:00 0.5 https://ir.markertherapeutics.com/investor-relations 2021-02-03T17:15:53-05:00 0.8 https://ir.markertherapeutics.com/corporate-profile 2021-01-14T13:03:35-05:00 0.8 https://ir.markertherapeutics.com/news-events/press-releases 2022-01-27T16:12:36-05:00 0.8 https://ir.markertherapeutics.com/news-events/events-presentations 2025-11-12T17:23:22-05:00 0.8 https://ir.markertherapeutics.com/corporate-governance/documents-charters 2021-01-12T14:21:21-05:00 0.8 https://ir.markertherapeutics.com/corporate-governance/committee-composition 2020-11-30T18:56:10-05:00 0.8 https://ir.markertherapeutics.com/financials-filings/annual-reports-proxies 2021-01-15T16:52:37-05:00 0.8 https://ir.markertherapeutics.com/stock-information/analyst-coverage 2021-01-15T02:29:24-05:00 0.8 https://ir.markertherapeutics.com/stock-information/stock-quote-chart 2021-02-01T11:56:58-05:00 0.8 https://ir.markertherapeutics.com/stock-information/historic-price-lookup 2018-04-09T13:55:32-04:00 0.8 https://ir.markertherapeutics.com/investor-resources/investor-faqs 2021-01-14T13:32:35-05:00 0.8 https://ir.markertherapeutics.com/investor-resources/email-alerts 2021-01-14T13:33:35-05:00 0.8 https://ir.markertherapeutics.com/investor-resources/investor-contact 2021-01-14T13:33:03-05:00 0.8 https://ir.markertherapeutics.com/financials-filings/quarterly-results 2021-01-22T14:31:40-05:00 0.8 https://ir.markertherapeutics.com/financials-filings/sec-filings 2021-01-12T14:19:00-05:00 0.8 https://ir.markertherapeutics.com/stock-information/irs-form-8937 2023-03-08T13:58:11-05:00 0.8 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2020-operating-and 2020-11-30T14:56:40-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-third-quarter-2020-operating-and 2020-11-30T14:58:55-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-virtual-oppenheimer-fall-healthcare 2020-11-30T14:59:51-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-second-quarter-2020-operating-and 2020-11-30T18:59:22-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-new-manufacturing-facility-support 2020-11-30T19:00:56-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-receives-usan-approval-zelenoleucel 2020-11-30T19:04:45-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-present-two-upcoming-cellular-therapy-conferences 2020-12-01T14:51:14-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-inc-announces-new-executive-appointments 2020-12-01T15:02:47-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-three-upcoming-healthcare 2020-12-01T15:06:58-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-inc-appoints-anthony-h-kim-chief-financial 2020-12-01T15:10:38-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/center-cell-and-gene-therapy-baylor-college-medicine-present 2020-12-01T15:17:55-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-tumor-targeted-lymphocytes-summit 2020-12-01T15:21:34-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-provides-updates-its-lead-clinical-programs 2020-12-01T15:37:30-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/center-cell-and-gene-therapy-baylor-college-medicine-present-0 2020-12-01T15:40:06-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-phacilitate-leaders-world-world-stem 2020-12-01T15:42:54-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-2019-bio-ceo-investor-conference 2020-12-01T15:46:06-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-appoints-mythili-koneru-md-phd-senior-vice 2020-12-01T15:50:49-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-change-corporate-headquarters-and 2020-12-01T15:55:27-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-car-tcr-summit-europe 2020-12-01T16:09:41-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-congratulates-helen-e-heslop-md-dsc-hon 2020-12-01T16:13:25-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-clinical-update-transplantation 2020-12-01T16:14:31-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-business-update-conference-call-and 2020-12-01T16:17:49-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-provides-business-and-clinical-update 2020-12-01T16:29:13-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-bank-america-merrill-lynch-health 2020-12-01T16:36:07-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-first-quarter-2019-operating-and 2020-12-01T16:38:52-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-two-upcoming-investor-conferences 2020-12-01T16:50:05-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-report-updated-results-phase-12-trial-0 2020-12-01T16:55:46-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-conference-call-and-webcast-review 2020-12-01T17:31:24-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-interim-results-its-multitaa-t-cell 2020-12-01T17:33:43-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-appoints-steve-elms-its-board-directors 2020-12-01T17:36:49-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-second-quarter-2019-operating-and 2020-12-01T17:38:45-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-appoints-nadia-agopyan-phd-rac-vice 2020-12-01T17:40:24-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-third-quarter-2019-operating-and 2020-12-01T17:45:27-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2019-operating-and 2020-12-01T17:47:30-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-two-upcoming-investor-conferences-0 2020-12-01T17:48:38-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-update-its-clinical-program-aml 2020-12-01T17:54:32-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-two-upcoming-investor-conferences-1 2020-12-01T17:55:33-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-and-aspire-capital-enter-common-stock 2020-12-01T17:56:36-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-full-year-2019-operating-and 2020-12-01T17:59:56-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-receives-fda-orphan-drug-designation-its 2020-12-01T18:01:57-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-first-quarter-2020-operating-and 2020-12-01T18:03:51-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-first-quarter-2020-operating-and 2020-12-01T18:05:26-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-report-updated-results-phase-12-trial-1 2020-12-01T18:09:02-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-interim-results-its-multitaa 2020-12-01T18:10:17-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/tapimmune-and-marker-therapeutics-announce-successful-closing 2020-12-09T15:20:57-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-fda-lifted-partial-clinical-hold 2021-01-26T18:36:37-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-completion-new-manufacturing 2021-01-26T18:35:43-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-dosing-first-patient-phase-2-trial 2021-03-03T07:03:06-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-fiscal-year-2020-operating-and 2021-03-09T16:13:48-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-inc-announces-proposed-public-offering 2021-03-11T16:11:55-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-inc-announces-pricing-public-offering-common 2021-03-12T08:02:40-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-virtual-oppenheimer-31st-annual 2021-03-15T07:02:46-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-inc-announces-closing-public-offering-common 2021-03-16T16:59:54-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-multi-tumor-associated-antigen-mtaa 2021-05-03T14:40:07-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-first-quarter-2021-operating-and 2021-04-29T16:10:55-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-first-quarter-2021-operating-and 2021-05-12T16:10:25-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-virtual-raymond-james-human-health 2021-06-16T16:07:16-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-completion-safety-lead-portion 2021-07-06T07:02:18-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-opening-new-cgmp-manufacturing 2021-07-28T16:08:24-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-second-quarter-2021-operating-and 2021-08-10T16:02:50-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-awarded-131-million-grant-cancer-prevention 2021-08-19T16:07:18-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-three-upcoming-september-investor 2021-09-07T16:08:24-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2021-operating-and 2021-11-10T16:13:14-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-data-investigator-sponsored-phase 2021-11-18T16:10:16-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-appoints-biotech-executive-katharine-knobil 2021-12-09T07:03:05-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-receives-fda-orphan-drug-designation-its-0 2022-01-19T17:06:03-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-host-clinical-program-update-conference-call 2022-02-08T16:06:21-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-clinical-program-updates-and 2022-02-16T16:32:19-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-two-upcoming-march-investor 2022-03-07T16:08:18-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-fiscal-year-2021-operating-and 2022-03-17T17:46:41-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-entry-services-agreement-wilson 2022-04-26T07:01:47-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-four-posters-its-t-cell-based 2022-05-04T10:32:15-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-q1-2022-operating-and-financial 2022-05-13T07:00:57-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-fda-clearance-ind-mt-601-six 2022-08-04T16:38:20-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-q2-2022-operating-and-financial 2022-08-11T16:23:05-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-participate-cantor-fitzgerald-cell-and 2022-09-08T07:00:47-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-awarded-2-million-grant-us-fda-support 2022-09-13T07:00:34-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-q3-2022-operating-and-financial 2022-11-10T16:05:54-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-fda-clearance-ind-mt-601-its-six 2022-11-22T07:00:35-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-and-lincoln-park-capital-enter-common-stock 2022-12-13T07:00:45-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-fiscal-year-2022-corporate-and 2023-03-22T08:10:50-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-comprehensive-non-dilutive 2023-05-01T07:30:31-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-appoints-monic-stuart-md-chief-medical 2023-05-08T07:30:34-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-pre-clinical-data-its-mt-601 2023-05-31T06:30:44-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-first-lymphoma-patient-treated-mt 2023-06-12T07:01:02-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-mt-401-non-clinical-data-aml-cells 2023-06-26T07:00:46-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/european-medicines-agency-grants-orphan-drug-designation-mt-401 2023-07-10T07:00:41-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-participate-virtual-roundtable-key-opinion 2023-07-26T07:00:49-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-non-clinical-proof-concept-data-and 2023-08-07T07:00:40-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-second-quarter-2023-financial 2023-08-14T16:30:46-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-hc-wainwright-25th-annual-global 2023-08-30T08:01:56-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-complete-response-first-lymphoma 2023-09-11T07:01:57-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2023-financial-results 2023-11-09T17:00:27-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-sustained-complete-response-first 2023-12-11T07:00:48-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-participation-biotech-showcase-and 2023-12-21T11:00:26-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-clinical-program-updates-and-0 2024-01-08T08:25:06-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-receives-approval-united-states-adopted-name 2024-01-22T07:30:22-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-hc-wainwright-2nd-annual-cell 2024-03-22T12:31:20-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-year-end-2023-corporate-and 2024-03-25T17:47:23-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/principal-investigator-city-hope-national-medical-center-invited 2024-04-08T07:00:57-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-first-quarter-2024-financial-results 2024-05-15T16:15:48-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-awarded-2-million-grant-nih-support-phase-1 2024-08-12T07:01:29-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-second-quarter-2024-financial 2024-08-14T16:31:17-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2024-financial-results 2024-11-14T16:36:51-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-citizens-jmp-hematology-and-oncology 2024-11-26T11:00:46-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-2024-ladenburg-thalmann-co-virtual 2024-12-10T08:30:58-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-awarded-95-million-grant-cancer-prevention 2024-12-17T07:00:40-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-provides-clinical-update-mt-601-patients 2024-12-19T08:06:13-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-161-million-private-placement 2024-12-19T08:07:03-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-hc-wainwright-3rd-annual-cell 2025-02-25T07:01:53-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-year-end-2024-corporate-and 2025-03-31T08:45:22-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-canaccord-genuitys-horizons-oncology 2025-04-01T08:01:20-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-spotlight-multi-antigen-recognizing-mar-t 2025-05-19T08:00:55-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-lymphodepletion-improves-expansion 2025-05-20T08:02:47-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-and-cellipont-bioservices-announce 2025-06-17T08:01:35-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-participate-fireside-chat-canaccord-genuity 2025-07-30T08:01:26-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-provides-update-phase-1-apollo-study 2025-08-26T07:35:58-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-participate-fireside-chat-hc-wainwright-27th 2025-08-28T08:01:07-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-first-patient-treated-shelf 2025-10-06T07:31:29-04:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-upcoming-presentations-mt-601 2025-11-03T09:15:19-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-appoints-kathryn-penkus-corzo-board 2025-11-05T07:30:28-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-third-quarter-2025-financial-results 2025-11-14T07:00:49-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/baylor-college-medicine-publishes-promising-safety-and-efficacy 2026-01-05T07:01:03-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/good-morning-america-features-baylor-college-medicine-pancreatic 2026-01-26T07:00:58-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-present-oppenheimer-36th-annual-healthcare 2026-02-18T08:01:46-05:00 0.5 https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-year-end-2025-corporate-and 2026-03-18T17:33:00-04:00 0.5 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0000912282-00-000063 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0000912282-00-000064 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0000912282-00-000116 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0000912282-00-000128 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0000912282-00-000142 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0000912282-00-000284 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0000912282-00-000321 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10sb12g/0000912282-99-000132 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10sb12ga/0000912282-99-000151 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0000912282-99-000212 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0000950134-05-006676 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0000950134-05-007541 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksba/0000950134-05-008565 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0000950134-05-010659 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0000950134-05-018628 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pres14a/0001000096-01-500049 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-01-500121 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-01-500122 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001000096-02-000280 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000281 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000282 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000291 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000293 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000295 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000296 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001000096-02-000297 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14c/0001000096-02-000342 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001035704-05-000078 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001035704-05-000127 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001035704-05-000269 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001035704-05-000464 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001035704-05-000474 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001035704-05-000609 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001035704-05-000671 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001035704-05-000685 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-00-001261 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-00-001320 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-01-000232 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-01-000233 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-01-000267 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-01-000268 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-01-000269 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-01-000270 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001050502-01-000366 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-ka/0001050502-01-000367 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/prer14a/0001050502-01-500022 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defs14a/0001050502-01-500046 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-01-500120 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-01-500190 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001050502-01-500351 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001050502-01-500368 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001050502-01-500592 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-000109 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-02-000110 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001050502-02-000388 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-000410 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000415 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-02-000416 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/prer14c/0001050502-02-000434 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-000435 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14c/0001050502-02-000455 2012-12-08T10:40:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001144204-13-001044 2013-01-07T16:02:55-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-13-010781 2013-02-25T06:03:37-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001079974-13-000111 2013-02-27T13:32:02-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-02-047867 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdexa/9999999997-02-057758 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-02-059241 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdexa/9999999997-02-061666 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-04-005239 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-04-027333 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-07-007607 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-07-046341 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/regdex/9999999997-08-036309 2013-03-27T21:07:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001554757-13-000191 2013-04-02T13:40:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0001140361-13-016325 2013-04-12T13:03:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001554757-13-000319 2013-05-15T17:31:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001554757-13-000330 2013-05-16T13:55:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001554757-13-000346 2013-05-21T06:11:11-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-13-000034 2013-08-13T12:10:41-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-13-000038 2013-08-19T16:45:39-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-qa/0001424884-13-000037 2013-08-19T16:45:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0001144204-13-052085 2013-09-24T11:03:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001144204-13-052112 2013-09-24T12:47:42-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-13-000058 2013-11-15T06:55:32-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001589728-13-000008 2013-11-19T17:13:44-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-14-000002 2014-01-07T12:38:19-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14c/0001424884-14-000011 2014-01-17T09:15:39-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001140361-14-002820 2014-01-22T10:54:58-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14c/0001424884-14-000017 2014-01-28T13:36:19-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-14-000033 2014-03-03T12:25:57-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001424884-14-000037 2014-04-01T14:44:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001424884-14-000046 2014-04-15T17:21:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-ka/0001424884-14-000048 2014-04-17T06:05:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-14-000053 2014-05-15T11:19:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001424884-14-000061 2014-05-20T17:21:15-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-14-000060 2014-05-20T17:21:16-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-qa/0001424884-14-000063 2014-05-21T16:37:08-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3a/0001424884-14-000070 2014-07-21T14:09:16-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-14-000076 2014-07-23T14:34:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-14-002196 2014-07-24T06:07:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001424884-14-000084 2014-08-13T16:47:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-14-000086 2014-08-14T12:48:46-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-14-000090 2014-08-14T17:31:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-14-000092 2014-08-18T15:44:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0000902664-14-003653 2014-08-25T08:20:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-14-000114 2014-11-10T17:01:46-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-14-000117 2014-11-14T13:36:33-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-14-000121 2014-11-19T16:59:43-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001424884-15-000003 2015-01-12T08:41:30-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0001213900-15-000196 2015-01-12T12:05:37-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000006 2015-01-12T12:08:37-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0000902664-15-000091 2015-01-12T16:23:51-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0000902664-15-000096 2015-01-12T16:56:51-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001424884-15-000028 2015-03-09T17:11:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000030 2015-03-10T17:17:13-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0000930413-15-001217 2015-03-13T16:24:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0001144204-15-016463 2015-03-16T17:38:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001408408-15-000024 2015-03-17T16:24:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001408408-15-000026 2015-03-17T17:12:37-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000032 2015-03-27T16:42:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ntn-10k/0001424884-15-000034 2015-04-02T06:09:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001424884-15-000039 2015-04-15T16:12:15-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-15-000050 2015-05-15T17:28:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-15-000030 2015-06-01T17:57:50-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000054 2015-06-03T06:11:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-15-000034 2015-06-03T09:56:51-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000057 2015-06-05T15:46:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-15-000036 2015-06-05T17:34:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-15-000038 2015-06-18T11:37:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-15-000040 2015-06-18T12:13:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000066 2015-06-19T11:41:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pos-am/0001424884-15-000069 2015-06-19T17:31:43-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pos-am/0001424884-15-000080 2015-07-08T07:06:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-15-001940 2015-07-17T06:05:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001424884-15-000093 2015-07-17T17:02:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-1/0001424884-15-000100 2015-07-20T17:19:18-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000105 2015-07-23T06:49:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000107 2015-07-27T15:45:57-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000110 2015-07-30T07:42:56-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-15-002218 2015-08-10T06:08:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001424884-15-000121 2015-08-11T16:51:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-15-000124 2015-08-14T18:31:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000140 2015-09-10T14:13:16-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-15-000044 2015-09-11T16:11:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-15-000046 2015-09-11T16:23:21-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-15-000048 2015-09-29T14:34:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0000899243-15-007779 2015-11-09T16:11:50-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-007780 2015-11-09T16:45:38-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008118 2015-11-13T16:11:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0000899243-15-008114 2015-11-13T16:11:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008131 2015-11-13T17:10:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008132 2015-11-13T17:10:20-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0000899243-15-008135 2015-11-13T17:27:17-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008138 2015-11-13T17:33:17-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008209 2015-11-16T17:07:16-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008211 2015-11-16T17:10:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-15-008210 2015-11-16T17:10:03-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-15-000168 2015-11-16T17:18:04-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001424884-15-000172 2015-11-20T12:33:33-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001424884-15-000174 2015-11-20T12:35:34-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-15-000181 2015-12-11T17:00:27-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0000902664-16-004887 2016-01-19T16:16:25-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-439649 2016-01-27T14:47:32-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0000899243-16-012296 2016-01-28T12:36:51-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-16-012297 2016-01-28T12:39:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-ka/0001193125-16-442180 2016-01-29T06:19:26-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001213900-16-010454 2016-01-29T09:55:21-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ct-order/9999999997-16-016567 2016-02-04T13:39:59-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001144204-16-079372 2016-02-08T06:08:35-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0000930413-16-005298 2016-02-08T17:31:47-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-465456 2016-02-16T16:54:40-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001193125-16-525058 2016-03-31T11:26:39-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-536320 2016-04-11T09:12:17-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-qa/0001193125-16-541449 2016-04-14T16:32:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-qa/0001193125-16-541467 2016-04-14T16:37:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-qa/0001193125-16-541488 2016-04-14T16:48:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001193125-16-541539 2016-04-14T16:55:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pos-am/0001193125-16-589082 2016-05-12T17:34:43-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001193125-16-591962 2016-05-16T17:25:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-602409 2016-05-25T17:15:15-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pos-am/0001193125-16-611325 2016-06-02T17:24:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001193125-16-618900 2016-06-10T14:33:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-16-004877 2016-06-13T06:06:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-649467 2016-07-15T17:01:51-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-650797 2016-07-19T09:50:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-16-025288 2016-07-19T15:02:39-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-678673 2016-08-11T08:48:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-16-000084 2016-08-12T16:43:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-16-000086 2016-08-12T16:56:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001193125-16-682054 2016-08-15T17:25:13-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001193125-16-682064 2016-08-15T17:25:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001213900-16-016258 2016-08-19T11:35:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001209191-16-138262 2016-08-23T14:13:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001094038-16-000005 2016-08-25T06:06:41-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-690727 2016-08-25T08:55:47-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0000899243-16-028030 2016-08-25T09:06:51-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000899243-16-028032 2016-08-25T09:06:51-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-695179 2016-08-29T12:45:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/da/0001094038-16-000006 2016-09-09T13:29:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-16-710452 2016-09-15T08:38:55-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001193125-16-710751 2016-09-15T13:49:03-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-a12b/0001144204-16-131272 2016-11-03T10:10:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-16-131724 2016-11-04T16:10:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001144204-16-131864 2016-11-07T08:37:30-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/certnas/9999999997-16-026716 2016-11-07T11:56:33-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ct-order/9999999997-16-026835 2016-11-15T16:37:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-16-137257 2016-11-30T16:25:06-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001524858-16-000008 2016-11-30T16:39:15-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001524858-16-000009 2016-11-30T16:54:14-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-16-139495 2016-12-14T16:36:54-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001144204-16-140950 2016-12-22T15:43:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-17-000144 2017-01-19T06:05:39-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001144204-17-002817 2017-01-19T08:05:42-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001213900-17-000948 2017-02-06T06:10:19-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001193805-17-000250 2017-02-14T18:13:31-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-014231 2017-03-13T16:05:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-014235 2017-03-13T16:05:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001144204-17-014490 2017-03-14T16:09:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-17-023264 2017-04-28T16:53:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-17-024823 2017-05-05T16:05:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-17-033502 2017-06-22T08:36:39-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-17-034074 2017-06-26T16:52:56-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001094038-17-000002 2017-06-29T13:57:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-17-036431 2017-07-11T16:03:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001144204-17-036528 2017-07-12T13:47:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-17-040922 2017-08-07T17:34:12-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001408408-17-000023 2017-08-25T11:24:14-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-045902 2017-08-30T16:04:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-045905 2017-08-30T16:06:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-045903 2017-08-30T16:06:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-045909 2017-08-30T16:09:56-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-045906 2017-08-30T16:09:58-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-17-046574 2017-09-05T16:04:16-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001144204-17-048887 2017-09-20T16:38:03-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3a/0001144204-17-049308 2017-09-22T17:35:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/del-am/0001144204-17-049336 2017-09-25T06:06:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-17-049357 2017-09-25T08:55:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-17-049441 2017-09-25T15:13:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-049443 2017-09-25T15:15:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-17-049725 2017-09-26T16:09:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-17-058991 2017-11-14T16:22:06-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3a/0001144204-17-065626 2017-12-28T15:43:16-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001144204-17-065906 2017-12-29T16:48:25-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-18-000012 2018-01-02T06:09:37-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001213900-18-000939 2018-01-26T16:21:50-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0000930413-18-000507 2018-02-14T18:05:21-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-012627 2018-03-02T17:59:38-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001144204-18-016734 2018-03-23T17:24:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001144204-18-016745 2018-03-23T17:32:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0000921895-18-001200 2018-04-04T16:36:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-028370 2018-05-15T07:06:56-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001144204-18-028371 2018-05-15T07:08:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-18-028862 2018-05-15T16:25:43-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-18-000005 2018-05-16T17:19:41-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-18-000007 2018-05-16T17:33:42-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-029884 2018-05-18T17:21:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001144204-18-030789 2018-05-24T16:10:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-033374 2018-06-08T09:24:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b7/0001144204-18-034436 2018-06-15T16:44:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b7/0001144204-18-035109 2018-06-21T12:36:03-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/prem14a/0001144204-18-038363 2018-07-13T17:24:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001144204-18-042863 2018-08-08T16:43:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-042861 2018-08-08T16:45:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-18-043366 2018-08-09T17:09:37-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/prer14a/0001571049-18-000475 2018-09-07T17:46:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defm14a/0001144204-18-049481 2018-09-14T14:58:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-050737 2018-09-25T17:07:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-053247 2018-10-10T16:55:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054101 2018-10-17T08:49:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054103 2018-10-17T08:51:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054105 2018-10-17T08:53:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054107 2018-10-17T08:57:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054109 2018-10-17T08:59:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-054209 2018-10-17T16:03:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-a12ba/0001144204-18-054210 2018-10-17T16:05:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055558 2018-10-18T16:51:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055562 2018-10-18T16:53:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055561 2018-10-18T16:53:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055560 2018-10-18T16:53:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055563 2018-10-18T16:53:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055559 2018-10-18T16:53:03-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055567 2018-10-18T16:55:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055566 2018-10-18T16:55:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055564 2018-10-18T16:55:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055569 2018-10-18T16:57:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055568 2018-10-18T16:57:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055570 2018-10-18T16:57:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-18-055571 2018-10-18T16:57:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-054557 2018-10-19T16:33:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-054565 2018-10-19T16:37:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-054562 2018-10-19T16:37:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054584 2018-10-19T16:55:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054586 2018-10-19T16:57:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001193125-18-303199 2018-10-19T17:13:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-054989 2018-10-23T17:12:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054993 2018-10-23T17:14:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054994 2018-10-23T17:14:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-054992 2018-10-23T17:14:41-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001072613-18-000512 2018-10-25T16:17:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-ka/0001144204-18-055613 2018-10-29T06:08:18-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-056154 2018-10-30T16:25:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001144204-18-056172 2018-10-30T16:49:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001144204-18-056186 2018-10-30T16:59:38-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-18-000021 2018-11-08T11:25:10-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-18-059353 2018-11-13T16:12:59-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001144204-18-060520 2018-11-16T16:31:59-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-18-002918 2018-11-19T06:03:28-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-061604 2018-11-27T09:19:06-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-061745 2018-11-27T17:06:57-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-18-062322 2018-11-29T16:09:56-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-062320 2018-11-29T16:09:57-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-062867 2018-12-03T16:15:57-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-18-062948 2018-12-04T06:06:10-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-066573 2018-12-28T16:16:29-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-066575 2018-12-28T16:18:30-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-18-066584 2018-12-28T16:36:30-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-000592 2019-01-04T12:39:14-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-001768 2019-01-15T17:19:53-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b7/0001144204-19-003213 2019-01-29T06:08:34-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001213900-19-001621 2019-02-04T09:33:42-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001144204-19-007747 2019-02-14T11:20:02-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001144204-19-007755 2019-02-14T11:24:02-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001144204-19-007762 2019-02-14T11:26:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13g/0001193125-19-040985 2019-02-14T17:24:20-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-008704 2019-02-15T16:58:59-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-009717 2019-02-25T08:56:50-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001144204-19-014350 2019-03-15T17:07:46-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-016685 2019-03-28T17:13:12-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001144204-19-016692 2019-03-28T17:19:12-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001144204-19-016699 2019-03-28T17:23:14-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ct-order/9999999997-19-002227 2019-04-01T14:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-019976 2019-04-17T07:04:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-024949 2019-05-09T17:13:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-19-025316 2019-05-10T17:06:41-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-025325 2019-05-10T17:08:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-19-025608 2019-05-13T16:04:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-19-025602 2019-05-13T16:04:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-19-025607 2019-05-13T16:04:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-19-025605 2019-05-13T16:04:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001144204-19-026544 2019-05-15T16:13:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001144204-19-030986 2019-06-14T16:08:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-031591 2019-06-20T07:07:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-19-001442 2019-06-26T06:02:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-035118 2019-07-19T09:18:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-035266 2019-07-22T08:38:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-037903 2019-08-06T17:26:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-19-045148 2019-08-08T17:29:14-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-19-045152 2019-08-08T17:55:11-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-038680 2019-08-09T06:22:46-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001144204-19-038714 2019-08-09T08:34:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-040272 2019-08-15T16:32:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-19-046149 2019-08-15T16:40:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-19-046625 2019-08-19T17:11:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-19-046630 2019-08-19T17:20:37-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-19-045766 2019-09-24T16:12:11-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-19-062594 2019-11-12T16:12:48-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-19-062634 2019-11-12T16:21:27-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-015276 2020-02-11T07:03:11-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13ga/0001193125-20-038347 2020-02-14T17:10:57-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-20-000008 2020-02-20T16:43:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-20-000011 2020-02-20T17:00:36-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-027550 2020-03-02T09:05:38-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001104659-20-028589 2020-03-03T16:44:22-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001104659-20-032463 2020-03-12T16:07:04-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-20-018519 2020-03-12T16:34:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-20-018515 2020-03-12T16:34:38-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018524 2020-03-12T16:38:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018528 2020-03-12T16:38:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018531 2020-03-12T16:39:55-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-032531 2020-03-12T16:39:57-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018534 2020-03-12T16:42:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018543 2020-03-12T16:44:11-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018535 2020-03-12T16:44:13-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018539 2020-03-12T16:44:15-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018548 2020-03-12T16:45:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-20-018556 2020-03-12T16:49:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-20-048175 2020-04-17T16:04:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-053395 2020-04-29T16:23:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-20-059515 2020-05-11T16:06:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-059559 2020-05-11T16:22:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-064746 2020-05-21T16:09:58-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-067357 2020-05-29T08:21:37-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-068051 2020-06-01T09:25:41-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001104659-20-072918 2020-06-12T16:20:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-20-000027 2020-06-18T16:45:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-20-000029 2020-06-19T07:52:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-075877 2020-06-23T08:58:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-078459 2020-06-30T09:32:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-20-092706 2020-08-10T16:06:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-092766 2020-08-10T16:34:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-20-123055 2020-11-09T16:33:35-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-20-123073 2020-11-09T16:36:16-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-20-000052 2020-11-13T16:19:42-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001408408-20-000054 2020-11-13T16:27:10-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-000891 2021-01-05T16:05:37-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-003664 2021-01-13T07:46:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001209191-21-010226 2021-02-12T17:15:38-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001209191-21-010224 2021-02-12T17:15:58-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001209191-21-010231 2021-02-12T17:18:23-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001209191-21-010241 2021-02-12T17:22:42-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001209191-21-010250 2021-02-12T17:23:39-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010256 2021-02-12T17:24:30-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010262 2021-02-12T17:26:21-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010267 2021-02-12T17:29:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010278 2021-02-12T17:32:47-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010285 2021-02-12T17:34:07-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010297 2021-02-12T17:37:08-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010302 2021-02-12T17:39:38-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010306 2021-02-12T17:39:58-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-010312 2021-02-12T17:41:21-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-21-027293 2021-02-24T11:44:41-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-031116 2021-03-03T07:47:16-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-033842 2021-03-09T16:39:04-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001104659-21-033855 2021-03-09T16:50:37-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001104659-21-035002 2021-03-11T16:08:40-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001104659-21-036276 2021-03-15T16:31:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001408408-21-000011 2021-03-15T16:46:53-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-037220 2021-03-16T17:20:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021771 2021-03-18T16:39:04-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021769 2021-03-18T16:39:14-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021773 2021-03-18T16:41:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021775 2021-03-18T16:41:27-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021809 2021-03-18T17:11:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021810 2021-03-18T17:13:21-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021811 2021-03-18T17:13:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021812 2021-03-18T17:14:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021813 2021-03-18T17:16:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021814 2021-03-18T17:18:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021817 2021-03-18T17:19:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021816 2021-03-18T17:19:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021815 2021-03-18T17:19:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-021818 2021-03-18T17:20:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001104659-21-040445 2021-03-24T06:05:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001072613-21-000318 2021-03-26T10:40:25-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-21-054483 2021-04-23T16:34:12-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001104659-21-054487 2021-04-23T16:36:32-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defr14a/0001104659-21-061740 2021-05-05T16:27:27-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-065132 2021-05-12T16:22:12-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-21-065131 2021-05-12T16:22:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-034427 2021-05-20T16:34:58-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-039629 2021-06-10T18:55:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-039631 2021-06-10T18:57:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-039632 2021-06-10T18:57:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-039634 2021-06-10T18:59:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-039635 2021-06-10T19:00:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-079831 2021-06-11T08:03:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-089167 2021-07-06T07:25:14-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-000517 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001050502-02-000519 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-ka/0001050502-02-000531 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-02-000534 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001050502-02-000535 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsba/0001050502-02-000661 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000662 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000672 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000674 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3a/0001050502-02-000678 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-02-000693 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000722 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000753 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000754 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-000759 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-000803 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-000804 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-000805 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-000806 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-000807 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-000820 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-000823 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001050502-02-000835 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001050502-02-000954 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4a/0001050502-02-000999 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-001010 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4a/0001050502-02-001034 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-001036 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4a/0001050502-02-001040 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4a/0001050502-02-001041 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001050502-02-001044 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001050502-02-001045 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001050502-02-001047 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000035 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000092 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000098 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000120 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000127 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000129 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000131 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000136 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001050502-03-000149 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001050502-03-000285 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0001050502-03-000335 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001050502-03-000596 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-00-000202 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001092306-01-000105 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0001092306-01-500007 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-01-500046 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-03-000224 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-03-000343 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-03-000569 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001092306-04-000054 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001092306-04-000119 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001092306-04-000120 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001092306-04-000121 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001092306-04-000122 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001092306-04-000123 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001092306-04-000124 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001092306-04-000125 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001092306-04-000126 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001092306-04-000127 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001092306-04-000128 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001092306-04-000133 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001092306-04-000134 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001092306-04-000135 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/5/0001092306-04-000136 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14a/0001092306-04-000143 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001092306-04-000151 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001092306-04-000175 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001092306-04-000202 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0001092306-04-000268 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsba/0001092306-04-000292 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8-pos/0001092306-04-000294 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001092306-04-000397 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-04-000415 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-04-000606 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001092306-04-000675 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001092306-04-000704 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001092306-04-000864 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-qa/0001092306-04-000870 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001092306-04-000878 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb40/0001108890-02-000130 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001140361-12-021069 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001140361-12-021071 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001140361-12-021225 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-07-066012 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001144204-08-003173 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-11-020269 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001144204-11-020285 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001171520-08-000195 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0001171520-08-000222 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001171520-08-000293 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001171520-08-000295 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001171520-08-000349 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-05-000148 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001183740-05-000155 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001183740-05-000174 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001183740-06-000024 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001183740-06-000063 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0001183740-06-000067 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksba/0001183740-06-000069 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001183740-06-000080 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-06-000091 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001183740-06-000159 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-06-000171 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001183740-06-000291 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-06-000307 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14a/0001183740-07-000082 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001183740-07-000103 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001183740-07-000162 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksb/0001183740-07-000209 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-07-000263 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsba/0001183740-07-000314 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsba/0001183740-07-000316 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsba/0001183740-07-000318 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001183740-07-000404 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001183740-07-000431 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001183740-07-000432 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001183740-07-000434 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001183740-07-000435 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001183740-07-000474 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13d/0001183740-07-000476 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-07-000549 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001183740-07-000762 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10qsb/0001183740-07-000771 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001183740-08-000366 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001183740-08-000418 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001183740-08-000433 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001183740-08-000445 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10ksba/0001183740-08-000466 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001183740-08-000588 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001183740-08-000598 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14a/0001183740-08-000648 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001183740-08-000691 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001183740-09-000054 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001183740-09-000111 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001183740-09-000120 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001183740-09-000136 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001183740-09-000485 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001183740-09-000486 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001183740-09-000554 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001183740-10-000161 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001208710-09-000001 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001208710-09-000002 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001292013-04-000001 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001362310-07-002550 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-09-000020 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-ka/0001424884-09-000029 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001424884-09-000033 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-09-000037 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-09-000053 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-09-000064 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-09-000078 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-09-000080 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-09-000084 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001424884-09-000089 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001424884-09-000090 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001424884-09-000091 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-09-000093 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14c/0001424884-10-000002 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14c/0001424884-10-000008 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-10-000010 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-10-000030 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001424884-10-000040 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-q/0001424884-10-000049 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-10-000060 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001424884-10-000064 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-10-000066 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001424884-10-000069 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001424884-10-000072 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-1/0001424884-10-000074 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/nt-10-k/0001424884-12-000021 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001531101-11-000001 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-10-002369 2021-07-09T20:00:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-096990 2021-07-28T16:39:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-21-102826 2021-08-10T16:07:04-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-102841 2021-08-10T16:15:15-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001104659-21-102945 2021-08-10T17:14:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-107740 2021-08-19T16:14:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-21-003254 2021-08-20T06:06:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001104659-21-107079 2021-09-18T00:05:15-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-21-010111 2021-09-18T00:06:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000035 2021-10-02T09:46:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-14-003827 2021-10-02T10:35:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-10-000097 2021-10-02T10:37:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-035927 2021-10-02T10:57:38-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-042246 2021-10-02T11:30:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-11-022163 2021-10-02T11:31:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000048 2021-10-02T12:00:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-17-059639 2021-10-02T12:11:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-11-061845 2021-10-02T12:49:16-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-10-041016 2021-10-02T13:10:12-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-15-000114 2021-10-02T13:18:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-000668 2021-10-02T13:37:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-10-000108 2021-10-02T13:44:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-11-025300 2021-10-02T13:53:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-14-000015 2021-10-02T13:58:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-15-040029 2021-10-02T13:59:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000124 2021-10-02T14:18:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-15-000087 2021-10-02T14:19:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000144 2021-10-02T14:25:58-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-17-050084 2021-10-02T14:40:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-08-044312 2021-10-02T14:41:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-15-036215 2021-10-02T16:10:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-044976 2021-10-02T16:19:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-11-011553 2021-10-02T16:22:27-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000059 2021-10-02T17:01:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000123 2021-10-02T17:08:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-039787 2021-10-02T17:24:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000099 2021-10-02T17:26:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-18-059361 2021-10-02T17:50:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-10-000109 2021-10-02T19:53:18-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-10-035876 2021-10-02T19:53:37-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-19-010106 2021-10-02T20:25:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000104 2021-10-02T20:27:13-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000083 2021-10-02T20:45:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-10-000156 2021-10-02T22:28:38-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-17-002361 2021-10-02T22:35:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000010 2021-10-02T23:07:08-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-17-065719 2021-10-02T23:35:03-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-14-005510 2021-10-02T23:39:11-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-19-031879 2021-10-02T23:39:48-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-18-035057 2021-10-02T23:43:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-11-037363 2021-10-02T23:54:47-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-10-077192 2021-10-03T00:21:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-034712 2021-10-03T00:26:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-16-078193 2021-10-03T00:28:39-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-17-034138 2021-10-03T00:40:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-11-034602 2021-10-03T00:53:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-08-037316 2021-10-03T02:06:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-11-000091 2021-10-03T02:06:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-17-052449 2021-10-03T02:10:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-15-000082 2021-10-03T02:51:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001424884-10-000089 2021-10-03T03:29:08-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001144204-17-062181 2021-10-03T03:48:08-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-21-000089 2021-11-10T16:15:15-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-136967 2021-11-10T16:32:13-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-138506 2021-11-15T07:13:02-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-21-147884 2021-12-09T08:02:56-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-21-068833 2021-12-09T17:20:28-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-21-068837 2021-12-09T17:22:22-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-005535 2022-01-20T06:03:04-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-024289 2022-02-16T16:34:19-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-025147 2022-02-18T16:07:27-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011745 2022-02-22T17:04:43-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011761 2022-02-22T17:05:26-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011769 2022-02-22T17:07:33-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011776 2022-02-22T17:09:33-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011782 2022-02-22T17:12:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011779 2022-02-22T17:13:00-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011786 2022-02-22T17:13:41-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011787 2022-02-22T17:14:17-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-011791 2022-02-22T17:16:16-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001410578-22-000418 2022-03-17T17:28:58-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-035160 2022-03-18T06:14:00-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001104659-22-035691 2022-03-18T17:24:28-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-021395 2022-03-28T21:14:43-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-021394 2022-03-28T21:14:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-021396 2022-03-28T21:14:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-043215 2022-04-06T16:11:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14a/0001104659-22-043219 2022-04-06T16:13:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-22-046490 2022-04-15T16:32:37-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-049970 2022-04-26T07:27:16-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-22-001389 2022-05-13T06:10:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-059849 2022-05-13T07:13:21-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-032172 2022-05-26T16:24:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-032166 2022-05-26T16:24:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-032175 2022-05-26T16:25:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-032180 2022-05-26T16:26:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-22-032169 2022-05-26T16:39:42-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001193125-22-162322 2022-05-27T16:26:01-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-086190 2022-08-04T16:52:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-22-002292 2022-08-11T16:41:21-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-089401 2022-08-11T16:43:55-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-8/0001104659-22-089426 2022-08-11T17:13:57-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-092803 2022-08-19T08:32:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-099500 2022-09-13T09:18:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-103164 2022-09-27T08:48:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-110309 2022-10-20T16:41:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-22-003131 2022-11-10T16:11:27-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-117148 2022-11-10T16:27:03-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-120986 2022-11-22T07:18:28-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-22-126446 2022-12-13T07:32:49-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-1/0001104659-22-129742 2022-12-23T09:02:56-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-000015 2023-01-03T06:09:55-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001104659-23-000118 2023-01-03T09:02:19-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-007019 2023-01-26T16:26:15-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001104659-22-130877 2023-02-06T05:24:00-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-22-013978 2023-02-06T05:26:35-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-014157 2023-03-01T16:54:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-014155 2023-03-01T16:54:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-014158 2023-03-01T16:54:39-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-014161 2023-03-01T16:56:58-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-014168 2023-03-01T16:57:49-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-014165 2023-03-01T16:58:04-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001213900-23-017251 2023-03-03T16:32:00-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-033300 2023-03-16T16:09:06-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001410578-23-000324 2023-03-22T08:04:46-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-035380 2023-03-22T08:22:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b5/0001104659-23-035382 2023-03-22T08:22:47-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-23-052923 2023-04-28T16:12:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ars/0001104659-23-052941 2023-04-28T16:13:31-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-053509 2023-05-01T07:38:02-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-056863 2023-05-08T07:47:24-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-028846 2023-05-11T18:12:34-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-23-001217 2023-05-15T16:14:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-066311 2023-05-31T06:47:21-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-035615 2023-06-08T21:39:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-035614 2023-06-08T21:39:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-035616 2023-06-08T21:48:57-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001209191-23-035617 2023-06-08T21:48:58-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-069896 2023-06-09T16:06:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-070151 2023-06-12T07:12:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-074513 2023-06-26T07:19:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-077074 2023-06-30T16:06:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-077598 2023-07-03T16:07:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001209191-23-041053 2023-07-05T16:24:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-079310 2023-07-10T07:15:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-088072 2023-08-07T07:24:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-23-001875 2023-08-14T16:12:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-091425 2023-08-14T16:39:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-099485 2023-09-11T07:13:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-23-002307 2023-11-09T16:37:20-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-116364 2023-11-09T17:05:58-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-119946 2023-11-20T16:39:06-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-23-124869 2023-12-11T07:38:54-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-002086 2024-01-08T08:37:35-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-027293 2024-02-26T08:01:15-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-029638 2024-03-01T08:06:58-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-038533 2024-03-26T06:06:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001410578-24-000297 2024-03-26T06:08:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-044496 2024-04-08T07:14:50-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-24-052914 2024-04-26T16:06:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ars/0001104659-24-052923 2024-04-26T16:10:17-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-24-000865 2024-05-15T16:07:27-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-062001 2024-05-15T16:45:44-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/sc-13da/0001072613-24-000515 2024-05-17T18:27:08-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-070830 2024-06-12T16:07:23-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-088054 2024-08-12T07:15:29-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-24-001454 2024-08-14T16:41:17-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-089704 2024-08-14T16:49:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-24-001978 2024-11-14T16:15:40-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-119077 2024-11-14T16:55:36-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001104659-24-123679 2024-11-27T16:30:07-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001104659-24-126320 2024-12-06T16:32:39-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-24-003698 2024-12-09T06:05:49-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-129181 2024-12-17T07:14:20-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-130002 2024-12-19T08:26:17-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-24-131322 2024-12-23T16:33:29-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0000950170-24-139630 2024-12-23T16:48:24-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-24-131704 2024-12-26T16:04:26-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/d/0001104659-24-132525 2024-12-30T16:48:26-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/s-3/0001104659-25-002600 2025-01-10T17:12:22-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-24-013351 2025-01-11T00:11:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001104659-24-125470 2025-01-11T00:14:10-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14a/0001104659-25-003033 2025-01-13T16:08:06-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b3/0001104659-25-004477 2025-01-17T16:14:23-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/effect/9999999995-25-000144 2025-01-21T06:05:16-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-007574 2025-01-30T16:07:46-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-25-009098 2025-02-04T16:07:03-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001104659-25-009099 2025-02-04T16:07:03-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/0001172661-25-001176 2025-02-14T16:27:13-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/0001140361-25-004890 2025-02-14T17:10:17-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-25-014317 2025-02-14T17:21:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-25-014315 2025-02-14T17:21:01-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-25-014318 2025-02-14T17:22:54-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-25-014321 2025-02-14T17:23:33-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/corresp/0001104659-25-003764 2025-02-19T00:08:11-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/upload/0000000000-25-000426 2025-02-19T00:08:11-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-015224 2025-02-19T17:04:03-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-ka/0001104659-25-020405 2025-03-04T17:12:30-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-028821 2025-03-27T17:02:40-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001410578-25-000549 2025-03-31T08:21:35-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-029666 2025-03-31T08:51:09-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-25-038633 2025-04-24T16:43:43-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001104659-25-038711 2025-04-24T16:44:57-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ars/0001104659-25-038714 2025-04-24T16:47:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001140361-25-019283 2025-05-15T16:14:30-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-25-001342 2025-05-15T17:05:10-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-050771 2025-05-20T08:34:14-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-057836 2025-06-09T16:14:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-060092 2025-06-17T08:04:22-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/424b7/0001104659-25-074154 2025-08-05T15:59:20-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-076834 2025-08-12T16:09:26-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001410578-25-001826 2025-08-14T17:17:52-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/schedule-13da/0001072613-25-000647 2025-08-18T17:35:49-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/schedule-13da/0001104659-25-080213 2025-08-19T14:45:45-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/schedule-13da/0001104659-25-080957 2025-08-20T16:59:05-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-082783 2025-08-26T07:22:59-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-096935 2025-10-06T07:33:54-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/3/0001884123-25-000009 2025-11-04T16:56:22-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001755495-25-000003 2025-11-04T17:05:41-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001884123-25-000010 2025-11-04T17:11:13-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-106669 2025-11-05T07:39:47-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-q/0001104659-25-111502 2025-11-13T18:02:45-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-25-111940 2025-11-14T07:22:59-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001172661-25-005191 2025-11-14T20:21:15-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/schedule-13da/0001072613-25-000858 2025-11-17T16:24:05-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001104659-25-114081 2025-11-19T16:04:18-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001270905-25-000003 2025-11-19T16:13:08-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/4/0001768011-25-000003 2025-11-19T16:24:23-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-26-012063 2026-02-09T16:11:07-05:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/pre-14a/0001104659-26-025917 2026-03-10T17:12:33-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/10-k/0001104659-26-031274 2026-03-18T17:40:39-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/8-k/0001104659-26-031309 2026-03-19T06:05:36-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/ars/0001104659-26-032704 2026-03-20T16:09:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/def-14a/0001104659-26-032694 2026-03-20T16:09:19-04:00 0.4 https://ir.markertherapeutics.com/sec-filings/sec-filing/defa14a/0001104659-26-032708 2026-03-20T16:09:39-04:00 0.4 https://ir.markertherapeutics.com/board-member/david-eansor 2020-11-30T18:29:44-05:00 0.5 https://ir.markertherapeutics.com/board-member/steven-elms 2020-11-30T18:30:31-05:00 0.5 https://ir.markertherapeutics.com/board-member/peter-hoang 2020-11-30T18:31:11-05:00 0.5 https://ir.markertherapeutics.com/board-member/david-laskow-pooley 2020-11-30T18:32:24-05:00 0.5 https://ir.markertherapeutics.com/board-member/frederick-wasserman 2020-11-30T18:50:33-05:00 0.5 https://ir.markertherapeutics.com/board-member/john-wilson 2020-11-30T18:35:41-05:00 0.5 https://ir.markertherapeutics.com/board-member/juan-vera 2020-11-30T18:36:36-05:00 0.5 https://ir.markertherapeutics.com/board-member/katharine-knobil-md 2022-08-15T13:42:54-04:00 0.5 https://ir.markertherapeutics.com/analyst/leah-cann-mba 2025-02-26T13:32:38-05:00 0.5 https://ir.markertherapeutics.com/analyst/john-newman-phd 2025-03-05T13:46:45-05:00 0.5 https://ir.markertherapeutics.com/analyst/steve-brozak-dmh-0 2025-04-11T12:48:49-04:00 0.5 https://ir.markertherapeutics.com/board-member/kathryn-penkus-corzo 2025-11-19T16:31:34-05:00 0.5 https://ir.markertherapeutics.com/analyst/patrick-trucchio 2026-01-26T08:32:15-05:00 0.5